François G Schellevis
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
François G Schellevis has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Alper M. VAN Sijl
Department of Rheumatology, VU University Medical Center, Amsterdam, The Netherlands
1 shared publication - Markus M. J. Nielen
Scientific Bureau, Dutch Institute for Clinical Auditing, Leiden, the Netherlands
1 shared publication - Michael T. Nurmohamed
Rheumatology, Amsterdam UMC Locatie VUmc, Amsterdam, The Netherlands
1 shared publication - Mike Jl Peters
Department of Internal Medicine, VU University Medical Centre, Amsterdam, Netherlands.
1 shared publication - Robert A. Verheij
Netherlands Institute for Health Services Research, Utrecht, The Netherlands
1 shared publication
Latest Publications
- Open Access
- 21 August 2012
- Published by Springer Nature in BMC Musculoskeletal Disorders
- Vol. 13 (1) , 150
Cardiovascular disease prevalence in patients with inflammatory arthritis, diabetes mellitus and osteoarthritis: a cross-sectional study in primary care
There is accumulating evidence for an increased cardiovascular burden in inflammatory arthritis, but the true magnitude of this cardiovascular burden is still debated. We sought to determine the prevalence rate of non-fatal cardiovascular disease (CVD) in inflammatory arthritis, diabetes mellitus and osteoarthritis (non-systemic inflammatory comparator) compared to controls, in primary care.
- 21 August 2012
- Published by Springer Nature in BMC Musculoskeletal Disorders
- Vol. 13 (1) , 150
Open AccessCardiovascular disease prevalence in patients with inflammatory arthritis, diabetes mellitus and osteoarthritis: a cross-sectional study in primary care
There is accumulating evidence for an increased cardiovascular burden in inflammatory arthritis, but the true magnitude of this cardiovascular burden is still debated. We sought to determine the prevalence rate of non-fatal cardiovascular disease (CVD) in inflammatory arthritis, diabetes mellitus and osteoarthritis (non-systemic inflammatory comparator) compared to controls, in primary care.